Sponsors (7)
The bill strengthens traceability, coordination, and oversight to reduce biosafety and biosecurity risks but does so at the cost of added compliance burdens, privacy and centralized-data security concerns, and reduced public transparency.
Researchers, hospitals, and public-health officials gain mandatory electronic transfer logs and authorized access to those logs, improving traceability of dangerous agents and speeding outbreak investigations and biosafety oversight.
Laboratories and repositories get a centralized, regularly updated federal list of 'highly pathogenic agents', giving clearer regulatory guidance about which materials require special handling.
State, local, Tribal, and territorial health officials get a single federal point of contact for biosafety and biosecurity questions, improving coordination during outbreaks or lab incidents.
Laboratories, biobanks, distributors, and other regulated entities will face increased compliance, reporting, and administrative costs to implement and maintain electronic logs, verification, and any new national standards.
Researchers and purchasers must provide personal identification and detailed intended-use information when acquiring agents, raising privacy risks if those records are mishandled or improperly accessed.
Broad disclosure allowances to multiple agencies and expanded authorized access to transfer data increase the number of entities that can view sensitive information, heightening the risk of misuse or unauthorized sharing.
Based on analysis of 3 sections of legislative text.
Requires electronic logbooks for transfers of federally listed highly pathogenic agents, directs HHS to list agents and issue rules, and designates a federal lead for periodic evaluations of BSL-3+ labs.
Introduced October 14, 2025 by Jim Costa · Last progress October 14, 2025
Requires covered distributors to keep electronic logbooks of all sales, leases, loans, or other transfers of a federal list of “highly pathogenic agents,” with purchaser identification, intended use, housing location, and other transaction details; entries must be retained at least three years. Directs HHS (through ASPR) to create and maintain the agents list (initial list due within six months and reviewed annually) and to issue implementing regulations. Directs the National Security Advisor to name a single federal entity to lead periodic strategic evaluations of U.S. high-containment (BSL-3+) laboratories, report findings to the President and Congress, establish a Public Health Biosafety and Biosecurity Team as a Federal point of contact within one year, and study the feasibility of a national database of high-containment labs (owners, addresses, licensing, violations, etc.).